<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:77bd633b-c568-4261-80ad-b8bba9fc5c92,g:d52712ef-5224-445f-8739-1573a193e819-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mdgl-20250331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_120f2a67-10f6-473a-9938-57380b6d0a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_fff7b78b-90a2-4eec-9952-a53799d8465e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_120f2a67-10f6-473a-9938-57380b6d0a7b" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_fff7b78b-90a2-4eec-9952-a53799d8465e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ffdd379a-2a6c-400d-8375-7a31084f850d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_120f2a67-10f6-473a-9938-57380b6d0a7b" xlink:to="loc_us-gaap_LiabilitiesCurrent_ffdd379a-2a6c-400d-8375-7a31084f850d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2a31cec5-42d8-482d-a640-28683f7d9a31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b4ff3a59-aa38-4bb8-a684-1eb74b551bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2a31cec5-42d8-482d-a640-28683f7d9a31" xlink:to="loc_us-gaap_StockholdersEquity_b4ff3a59-aa38-4bb8-a684-1eb74b551bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_24b1cf76-5f61-46b5-b1da-b9635f9ddf93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2a31cec5-42d8-482d-a640-28683f7d9a31" xlink:to="loc_us-gaap_Liabilities_24b1cf76-5f61-46b5-b1da-b9635f9ddf93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_acbadd80-8295-472f-9ffe-df0d6ccc6050" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a333d7d7-ec83-41fb-b7af-30ee53e553f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbadd80-8295-472f-9ffe-df0d6ccc6050" xlink:to="loc_us-gaap_CommonStockValue_a333d7d7-ec83-41fb-b7af-30ee53e553f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_690f9efd-272d-4f69-8b9b-1e7ee8d5fed4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbadd80-8295-472f-9ffe-df0d6ccc6050" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_690f9efd-272d-4f69-8b9b-1e7ee8d5fed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_607b366e-e69d-4a14-b287-3b1056db26e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbadd80-8295-472f-9ffe-df0d6ccc6050" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_607b366e-e69d-4a14-b287-3b1056db26e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bdd326d8-62f8-48ca-ad9e-97232f28beee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbadd80-8295-472f-9ffe-df0d6ccc6050" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bdd326d8-62f8-48ca-ad9e-97232f28beee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d9963c1d-10b5-4a25-90aa-e87346a0c33f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbadd80-8295-472f-9ffe-df0d6ccc6050" xlink:to="loc_us-gaap_PreferredStockValue_d9963c1d-10b5-4a25-90aa-e87346a0c33f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_57f563be-850c-471a-a743-5ace89066319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d89827e-06c9-4eb8-aee5-4fd53d72b0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57f563be-850c-471a-a743-5ace89066319" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d89827e-06c9-4eb8-aee5-4fd53d72b0d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8e31252f-a537-4d66-b077-20266902ca88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57f563be-850c-471a-a743-5ace89066319" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8e31252f-a537-4d66-b077-20266902ca88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b474f4ae-e2f8-47e8-8f60-bd87f83e3900" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57f563be-850c-471a-a743-5ace89066319" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b474f4ae-e2f8-47e8-8f60-bd87f83e3900" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9a40ab16-d91a-4208-9f9a-a1d34e71ecba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57f563be-850c-471a-a743-5ace89066319" xlink:to="loc_us-gaap_AssetsCurrent_9a40ab16-d91a-4208-9f9a-a1d34e71ecba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_71a11953-463b-4516-af39-8de834673ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2d1352a5-958f-404c-be71-11c440fd0d98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_71a11953-463b-4516-af39-8de834673ebc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2d1352a5-958f-404c-be71-11c440fd0d98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_f6394e3d-26c4-4f1f-9cdb-dde6b9c23b14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_71a11953-463b-4516-af39-8de834673ebc" xlink:to="loc_us-gaap_RestrictedCash_f6394e3d-26c4-4f1f-9cdb-dde6b9c23b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_82e561b8-6e13-4205-ba6b-357d613b4008" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_71a11953-463b-4516-af39-8de834673ebc" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_82e561b8-6e13-4205-ba6b-357d613b4008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6de04ec8-9766-41fe-9716-f4e078b13b96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_71a11953-463b-4516-af39-8de834673ebc" xlink:to="loc_us-gaap_InventoryNet_6de04ec8-9766-41fe-9716-f4e078b13b96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0cc761c1-f697-40b4-be90-0f02cc2d8305" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_71a11953-463b-4516-af39-8de834673ebc" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0cc761c1-f697-40b4-be90-0f02cc2d8305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a87ca02-7159-4200-8b17-1d87e705ea73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_71a11953-463b-4516-af39-8de834673ebc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a87ca02-7159-4200-8b17-1d87e705ea73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_5a0b0a86-b9a7-4978-83e7-5da474282ded" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_14ccf4b9-9da8-4802-9e7f-70fa61e85499" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5a0b0a86-b9a7-4978-83e7-5da474282ded" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_14ccf4b9-9da8-4802-9e7f-70fa61e85499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ec5bc940-f5be-4a0f-a70a-fd860f878e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5a0b0a86-b9a7-4978-83e7-5da474282ded" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ec5bc940-f5be-4a0f-a70a-fd860f878e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_be1091b4-99ae-4384-a532-c74f9eb83c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7352604a-d8b8-4a2c-8e90-f7bbae316470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be1091b4-99ae-4384-a532-c74f9eb83c0c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7352604a-d8b8-4a2c-8e90-f7bbae316470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2c19b0a3-290e-474b-8f06-69b6362d0e58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be1091b4-99ae-4384-a532-c74f9eb83c0c" xlink:to="loc_us-gaap_AccountsPayableCurrent_2c19b0a3-290e-474b-8f06-69b6362d0e58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_512b01f1-d2cc-44c6-a458-c42a57ab7f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be1091b4-99ae-4384-a532-c74f9eb83c0c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_512b01f1-d2cc-44c6-a458-c42a57ab7f1d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mdgl-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_05842fb2-9c7c-4631-89d3-4b67c774b780" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8d7c8cfd-1eef-4c95-8675-960b17e2b80d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_05842fb2-9c7c-4631-89d3-4b67c774b780" xlink:to="loc_us-gaap_InterestExpense_8d7c8cfd-1eef-4c95-8675-960b17e2b80d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1ae175c1-281b-4856-8ce1-0c640e53465f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_05842fb2-9c7c-4631-89d3-4b67c774b780" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1ae175c1-281b-4856-8ce1-0c640e53465f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fb6c6290-2100-489a-9314-c775f7e9bed4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_05842fb2-9c7c-4631-89d3-4b67c774b780" xlink:to="loc_us-gaap_OperatingIncomeLoss_fb6c6290-2100-489a-9314-c775f7e9bed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_46f2c869-85ee-449d-8885-410ee438218d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_16061b9b-1358-475a-b777-699d5d9667ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_46f2c869-85ee-449d-8885-410ee438218d" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_16061b9b-1358-475a-b777-699d5d9667ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_def70d31-7489-43da-9275-a04e3cedf18a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_46f2c869-85ee-449d-8885-410ee438218d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_def70d31-7489-43da-9275-a04e3cedf18a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_049da018-36d8-4d31-9ee6-3b5f0a8d4395" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_46f2c869-85ee-449d-8885-410ee438218d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_049da018-36d8-4d31-9ee6-3b5f0a8d4395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_34ee12d6-129a-4acd-80f3-53ff26f1b993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_484cc450-54bb-49bc-9295-6d14c557c7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_34ee12d6-129a-4acd-80f3-53ff26f1b993" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_484cc450-54bb-49bc-9295-6d14c557c7b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_388ce6b2-099d-46db-941f-5326641542a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_34ee12d6-129a-4acd-80f3-53ff26f1b993" xlink:to="loc_us-gaap_OperatingExpenses_388ce6b2-099d-46db-941f-5326641542a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="mdgl-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_33742fe8-5261-4d75-8244-2b4b875da708" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_904daa76-c5ea-4ced-9799-5aaf50793ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_33742fe8-5261-4d75-8244-2b4b875da708" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_904daa76-c5ea-4ced-9799-5aaf50793ff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f82633be-3f71-4727-9abd-5cf72aa3cfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_33742fe8-5261-4d75-8244-2b4b875da708" xlink:to="loc_us-gaap_NetIncomeLoss_f82633be-3f71-4727-9abd-5cf72aa3cfc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_4b6baeff-7b10-4929-b45a-da7e5a19dad0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_33742fe8-5261-4d75-8244-2b4b875da708" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_4b6baeff-7b10-4929-b45a-da7e5a19dad0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mdgl-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_fca2c753-304e-4502-977c-8f0975cdc83d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_fca2c753-304e-4502-977c-8f0975cdc83d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_08fca11d-e165-410b-808b-63572d5cee0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_08fca11d-e165-410b-808b-63572d5cee0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived_f3fc6ecf-98b1-4dc7-89b2-80a28949fb40" xlink:href="mdgl-20250331.xsd#mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived_f3fc6ecf-98b1-4dc7-89b2-80a28949fb40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_482edff6-4078-4a3f-a67c-36f5adf56bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_482edff6-4078-4a3f-a67c-36f5adf56bfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a34d70cf-07cd-4cc8-9f97-4eb83d6c1d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a34d70cf-07cd-4cc8-9f97-4eb83d6c1d4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_93a74c17-c49e-4da9-bc39-1149f39c23fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_ProfitLoss_93a74c17-c49e-4da9-bc39-1149f39c23fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_428fcfdf-0c16-44dd-b5d2-7397fcb6efc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_428fcfdf-0c16-44dd-b5d2-7397fcb6efc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_39647896-38fe-48d3-9334-78530249cda7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_ShareBasedCompensation_39647896-38fe-48d3-9334-78530249cda7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e1b77a26-7a5f-4acd-8e08-f1618dc020f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e1b77a26-7a5f-4acd-8e08-f1618dc020f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_31051429-dcec-4e4d-b9cd-4d4371b587b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_31051429-dcec-4e4d-b9cd-4d4371b587b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease_1b0b2822-4941-4b46-8797-140b0c029b2a" xlink:href="mdgl-20250331.xsd#mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bc4e698d-fb3c-4c6b-95a1-409b18a426a7" xlink:to="loc_mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease_1b0b2822-4941-4b46-8797-140b0c029b2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9e0bdb80-27b7-4ab0-8d27-747eefd3e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_15a6b402-b937-4056-a3d0-66bd1a5987b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9e0bdb80-27b7-4ab0-8d27-747eefd3e2ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_15a6b402-b937-4056-a3d0-66bd1a5987b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f3e085db-5ad2-4c59-85c9-14b8d32e7f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9e0bdb80-27b7-4ab0-8d27-747eefd3e2ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f3e085db-5ad2-4c59-85c9-14b8d32e7f7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_712b3ad1-10ad-4c20-a323-497c31bf2217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9e0bdb80-27b7-4ab0-8d27-747eefd3e2ea" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_712b3ad1-10ad-4c20-a323-497c31bf2217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a30cf6d-23b6-4cc9-b410-dd5a159aa305" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_7bb6047e-5c1b-4e7b-9353-a428bfb5dfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a30cf6d-23b6-4cc9-b410-dd5a159aa305" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_7bb6047e-5c1b-4e7b-9353-a428bfb5dfcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_09d0e33a-91b6-4099-b70d-5cc012eb431a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a30cf6d-23b6-4cc9-b410-dd5a159aa305" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_09d0e33a-91b6-4099-b70d-5cc012eb431a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_382fc259-5158-4dbf-8b73-8ca8614cc49f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a30cf6d-23b6-4cc9-b410-dd5a159aa305" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_382fc259-5158-4dbf-8b73-8ca8614cc49f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_664da1c5-e139-4650-a038-d82a9eaa912e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a30cf6d-23b6-4cc9-b410-dd5a159aa305" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_664da1c5-e139-4650-a038-d82a9eaa912e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2cd4fbce-285b-49ef-a83e-d2768d669a29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_dafc3034-9bf8-4a2a-b407-e973dd0b3a16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2cd4fbce-285b-49ef-a83e-d2768d669a29" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_dafc3034-9bf8-4a2a-b407-e973dd0b3a16" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="mdgl-20250331.xsd#CashCashEquivalentsRestrictedCashandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d0035177-c0b9-4abd-b38f-6bae0f6a7730" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4926c98b-fc39-4625-a357-c77babd0b6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d0035177-c0b9-4abd-b38f-6bae0f6a7730" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4926c98b-fc39-4625-a357-c77babd0b6f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_84ad7829-d3eb-484f-a743-71369ae6ce87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d0035177-c0b9-4abd-b38f-6bae0f6a7730" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_84ad7829-d3eb-484f-a743-71369ae6ce87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8dc871ad-2f65-4db5-9369-8e52ee7c8655" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d0035177-c0b9-4abd-b38f-6bae0f6a7730" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_8dc871ad-2f65-4db5-9369-8e52ee7c8655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_1b95437c-c2ae-4bab-81ea-eb3fe702b156" xlink:href="mdgl-20250331.xsd#mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dd04a45f-f94b-441f-82d7-2d540081aced" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_1b95437c-c2ae-4bab-81ea-eb3fe702b156" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_dd04a45f-f94b-441f-82d7-2d540081aced" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cac343c0-70e1-4100-8c07-1080783c4f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_1b95437c-c2ae-4bab-81ea-eb3fe702b156" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_cac343c0-70e1-4100-8c07-1080783c4f5c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1" xlink:type="simple" xlink:href="mdgl-20250331.xsd#CashCashEquivalentsRestrictedCashandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_43bdbf5f-b93a-413b-be58-4d147bef98f8" xlink:href="mdgl-20250331.xsd#mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1545e43f-2ab4-435c-a15a-b545965145c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_43bdbf5f-b93a-413b-be58-4d147bef98f8" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1545e43f-2ab4-435c-a15a-b545965145c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d37fbb8c-0ec6-47fe-8e6f-b1e94dca8230" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_43bdbf5f-b93a-413b-be58-4d147bef98f8" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d37fbb8c-0ec6-47fe-8e6f-b1e94dca8230" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0f109bfe-4061-4660-86b7-4e15bbc97502" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_43bdbf5f-b93a-413b-be58-4d147bef98f8" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0f109bfe-4061-4660-86b7-4e15bbc97502" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdgl-20250331.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7d651cd6-0e42-4ea6-a10c-81355f132479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7707d165-4d91-4337-851a-3904f640294a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7d651cd6-0e42-4ea6-a10c-81355f132479" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7707d165-4d91-4337-851a-3904f640294a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d6edf31b-dd04-449e-a5f3-e1d8c167cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7d651cd6-0e42-4ea6-a10c-81355f132479" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d6edf31b-dd04-449e-a5f3-e1d8c167cdd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_71845beb-dbcb-4b61-9a6b-804775b0617c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7d651cd6-0e42-4ea6-a10c-81355f132479" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_71845beb-dbcb-4b61-9a6b-804775b0617c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mdgl-20250331.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a1165647-8e72-4d1d-8393-ce0f9df2ee6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_f347119c-07f6-4a62-93ad-6b76928988b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a1165647-8e72-4d1d-8393-ce0f9df2ee6d" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_f347119c-07f6-4a62-93ad-6b76928988b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedLiabilitiesGross_edd9e644-6103-492a-9382-a09c087decb4" xlink:href="mdgl-20250331.xsd#mdgl_AccruedLiabilitiesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a1165647-8e72-4d1d-8393-ce0f9df2ee6d" xlink:to="loc_mdgl_AccruedLiabilitiesGross_edd9e644-6103-492a-9382-a09c087decb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent_9ae41845-eca4-4431-b62d-3604935f2473" xlink:href="mdgl-20250331.xsd#mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a1165647-8e72-4d1d-8393-ce0f9df2ee6d" xlink:to="loc_mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent_9ae41845-eca4-4431-b62d-3604935f2473" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_69feb7bf-adf8-47a9-929d-32c96830bff0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a1165647-8e72-4d1d-8393-ce0f9df2ee6d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_69feb7bf-adf8-47a9-929d-32c96830bff0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bfed59a3-d2de-40e9-9ab8-ace3dcc4fcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a1165647-8e72-4d1d-8393-ce0f9df2ee6d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bfed59a3-d2de-40e9-9ab8-ace3dcc4fcf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedContractResearchCostsCurrent_62e79c89-8602-423f-8048-2c50f842f336" xlink:href="mdgl-20250331.xsd#mdgl_AccruedContractResearchCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a1165647-8e72-4d1d-8393-ce0f9df2ee6d" xlink:to="loc_mdgl_AccruedContractResearchCostsCurrent_62e79c89-8602-423f-8048-2c50f842f336" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedManufacturingAndDrugSupplyCurrent_15074f12-df6f-4f56-b1dc-0470a2d98bef" xlink:href="mdgl-20250331.xsd#mdgl_AccruedManufacturingAndDrugSupplyCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a1165647-8e72-4d1d-8393-ce0f9df2ee6d" xlink:to="loc_mdgl_AccruedManufacturingAndDrugSupplyCurrent_15074f12-df6f-4f56-b1dc-0470a2d98bef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="mdgl-20250331.xsd#LongTermDebtMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/LongTermDebtMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1bd15145-bd5b-4a3f-b1bc-024b29f57696" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_LongTermDebtMaturityAfterYearTwo_c998ca64-578c-4b78-8d85-e0528628a4c7" xlink:href="mdgl-20250331.xsd#mdgl_LongTermDebtMaturityAfterYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1bd15145-bd5b-4a3f-b1bc-024b29f57696" xlink:to="loc_mdgl_LongTermDebtMaturityAfterYearTwo_c998ca64-578c-4b78-8d85-e0528628a4c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_99e728b6-d261-4c06-a797-66c1df588890" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1bd15145-bd5b-4a3f-b1bc-024b29f57696" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_99e728b6-d261-4c06-a797-66c1df588890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_a6a3a3ff-6761-47cc-933b-5bbbb771f3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1bd15145-bd5b-4a3f-b1bc-024b29f57696" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_a6a3a3ff-6761-47cc-933b-5bbbb771f3a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1e8d30bb-e7ff-4685-8644-ebffcb02a61a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_1bd15145-bd5b-4a3f-b1bc-024b29f57696" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1e8d30bb-e7ff-4685-8644-ebffcb02a61a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/SegmentInformationScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mdgl-20250331.xsd#SegmentInformationScheduleofSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/SegmentInformationScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_28dcb880-ddb3-4822-b7ad-c59da6e57194" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_ResearchAndDevelopmentExpensePersonnelAndInternal_08cf16bf-ac55-4d4c-8284-5bc6b7c923e2" xlink:href="mdgl-20250331.xsd#mdgl_ResearchAndDevelopmentExpensePersonnelAndInternal"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_28dcb880-ddb3-4822-b7ad-c59da6e57194" xlink:to="loc_mdgl_ResearchAndDevelopmentExpensePersonnelAndInternal_08cf16bf-ac55-4d4c-8284-5bc6b7c923e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2a04a573-3879-4706-be1a-cee967bb4eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_28dcb880-ddb3-4822-b7ad-c59da6e57194" xlink:to="loc_us-gaap_Revenues_2a04a573-3879-4706-be1a-cee967bb4eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6b7172f8-6011-4f8c-8238-bdd56d42a29f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_28dcb880-ddb3-4822-b7ad-c59da6e57194" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6b7172f8-6011-4f8c-8238-bdd56d42a29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b759ce10-ccda-42c1-aa52-b1ae2e41c2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_28dcb880-ddb3-4822-b7ad-c59da6e57194" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b759ce10-ccda-42c1-aa52-b1ae2e41c2fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_ResearchAndDevelopmentExternalExpense_132198d2-e5c3-4dd5-b220-df7b9b648a62" xlink:href="mdgl-20250331.xsd#mdgl_ResearchAndDevelopmentExternalExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_28dcb880-ddb3-4822-b7ad-c59da6e57194" xlink:to="loc_mdgl_ResearchAndDevelopmentExternalExpense_132198d2-e5c3-4dd5-b220-df7b9b648a62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_97cd5acf-528f-4209-9c67-246312ae95bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_28dcb880-ddb3-4822-b7ad-c59da6e57194" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_97cd5acf-528f-4209-9c67-246312ae95bb" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
